S'abonner

Cervical cancer disparities in stage at presentation for disaggregated Asian Americans, Native Hawaiians, and Pacific Islanders - 21/09/24

Doi : 10.1016/j.ajog.2024.08.027 
Frances Dominique V. Ho, MD a, Advait Thaploo, BS b, Katarina Wang, BS c, Aditya Narayan, BS d, Isabelle Rose I. Alberto, MD a, Erika P. Ong, MD a, Khushi Kohli, BS e, Mahi Kohli f, Bhav Jain, BS d, Edward Christopher Dee, MD g, Scarlett Lin Gomez, MPH, PhD h, i, James Janopaul-Naylor, MD g, Fumiko Chino, MD g,
a College of Medicine, University of the Philippines - Manila, Manila, Philippines 
b University of Pennsylvania, Philadelphia, PA 
c School of Medicine and Dentistry, University of Rochester, Rochester, NY 
d Stanford University School of Medicine, Stanford, CA 
e Harvard University, Cambridge, MA 
f Olathe North High School, Olathe, KS 
g Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 
h Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 
i Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 

Corresponding author: Fumiko Chino, MD.
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Saturday 21 September 2024

Abstract

Background

Over 20 million people in the United States identified as Asian American, Native Hawaiian, or Pacific Islander in 2022. Despite the diversity of immigration histories, lived experiences, and health needs within the Asian American, Native Hawaiian, or Pacific Islander community, prior studies in cervical cancer have considered this group in aggregate.

Objective

We sought to analyze disparities in cervical cancer stage at presentation in the United States, focusing on disaggregated Asian American, Native Hawaiian, or Pacific Islander groups.

Study Design

Data from the United States National Cancer Database from 2004 to 2020 of 122,926 patients newly diagnosed with cervical cancer were retrospectively analyzed. Asian American, Native Hawaiian, or Pacific Islander patients were disaggregated by country of origin. Logistic regression, adjusted for clinical and sociodemographic factors, was used to calculate adjusted odds ratios. Higher adjusted odds ratios indicate an increased likelihood of metastatic versus nonmetastatic disease at diagnosis.

Results

Out of 122,926 patients with cervical cancer, 5142 (4.2%) identified as Asian American, Native Hawaiian, or Pacific Islander. Compared to non-Hispanic White patients, pooled Asian American, Native Hawaiian, or Pacific Islander patients presented at lower stages of cancer (non-Hispanic White: 58.7% diagnosed local/regional, Asian American, Native Hawaiian, or Pacific Islander : 85.6% at local/regional, χ2 P<.001). The largest Asian American, Native Hawaiian, or Pacific Islander subgroups included Filipino Americans (n=1051, 20.4% of Asian American, Native Hawaiian, or Pacific Islander), Chinese Americans (n=995, 19.4%), Asian Indian/Pakistani Americans (n=711, 13.8%), Vietnamese Americans (n=627, 12.2%), and Korean Americans (n=550, 10.7%) respectively. Asian American, Native Hawaiian, or Pacific Islander disaggregation revealed that Pacific Islander American patients had higher odds of presenting with metastatic disease (adjusted odds ratio 1.58, 95% confidence interval 1.21–2.06, P=.001) relative to non-Hispanic White patients. Conversely, Chinese American (adjusted odds ratio 0.47, 95% confidence interval 0.37–0.59, P<.001), Vietnamese American (adjusted odds ratio 0.54, 95% confidence interval 0.41–0.70, P<.001), Hmong American (adjusted odds ratio 0.46, 95% confidence interval 0.22–0.97, P=.040), and Indian/Pakistani American (adjusted odds ratio 0.76, 95% confidence interval 0.61–0.94, P=.013) patients were less likely to present with metastatic disease. Compared to the largest Asian American, Native Hawaiian, or Pacific Islander group (Chinese American), 9 other subgroups were more likely to present with metastatic disease. The largest differences were observed in Pacific Islander American (adjusted odds ratio 3.44, 95% confidence interval 2.41–4.91, P<.001), Thai American (adjusted odds ratio 2.79, 95% confidence interval 1.41–5.53, P=.003), Kampuchean American (adjusted odds ratio 2.39, 95% confidence interval 1.29–4.42, P=.006), Native Hawaiian American (adjusted odds ratio 2.23, 95% confidence interval 1.37–3.63, P=.001), and Laotian American (adjusted odds ratio 2.02, 95% confidence interval 1.13–3.61, P=.017). In contrast, Vietnamese American (adjusted odds ratio 1.20, 95% confidence interval 0.85–1.71, P=.303), and Hmong American (adjusted odds ratio 1.09, 95% confidence interval 0.50–2.37, P=.828) patients did not show a statistically significant difference in presenting with metastatic disease compared to Chinese American patients.

Conclusion

Aggregated evaluation of the Asian American, Native Hawaiian, or Pacific Islander monolith masks disparities in outcomes for distinct populations at risk for equity gaps. This disaggregation study shows that marginalized groups within the larger Asian American, Native Hawaiian, or Pacific Islander population—including Pacific Islander American and Thai American patients—may face different exposures and larger structural barriers to cancer screening and early-stage diagnosis. A future focus on community-based disaggregated research and tailored interventions is necessary to close these gaps.

Le texte complet de cet article est disponible en PDF.

Key words : cancer disparities, cervical cancer


Plan


 A.T. and F.D.V.H. contributed equally as co-first authors to the study.
 The authors report no conflict of interest.
 E.C.D., J.J.N., and F.C. are all funded in part through the Cancer Center Support Grant from the National Cancer Institute (P30 CA008748).
 Cite this article as: Ho FDV, Thaploo A, Wang K, et al. Cervical cancer disparities in stage at presentation for disaggregated Asian Americans, Native Hawaiians, and Pacific Islanders. Am J Obstet Gynecol 2024;XXX:XX–XX.


© 2024  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.